Alessandro Di Federico

机构：Azienda USL di Bologna, University of Bologna

发表论文 1 篇 · 总被引 1 次 · h-index 1

代表论文

• Clinicogenomic determinants of early progression on first-line osimertinib in EGFR -mutant NSCLC. (2026 · Journal of Clinical Oncology · 被引 1)